ESC 365 - Zofenopril combined with xanthine oxidase inhibitors may improve survival in post-myocardial infarction patients as compared to placebo or other ACE-inhibitors

HFA Premium Access

Zofenopril combined with xanthine oxidase inhibitors may improve survival in post-myocardial infarction patients as compared to placebo or other ACE-inhibitors

Session: Clinical Forum - Mon. 23 May 08:30 - Tues. 24 May 12:30

Topic: Renin-angiotensin-aldosterone antagonists

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

22 more presentations in this session

Long-term effects and sustainability of collaborative disease management in systolic heart failure - the extended interdisciplinary network heart failure study

Speaker: Professor C. Angermann (Wurzburg, DE)

An implantable pressure sensor for long-term wireless monitoring of cardiac function -first study in man

Speaker: Doctor J. Baranowski (Linkoping, SE)

Heart failure hospitalisation or cardiovascular death with empagliflozin in patients with type 2 diabetes and high cardiovascular risk: analysis over time in EMPA-REG OUTCOME

Speaker: Doctor D. Fitchett (Toronto, CA)

Long-term safety and efficacy of sodium zirconium cyclosilicate (ZS-9) in the treatment of hyperkalaemia: interim analysis of ZS-005, an open-label phase 3 study

Speaker: Professor S. Anker (Berlin, DE)

Characteristics of myocardial deformation parameters and their prognostic impact in patients with hypertrophic cardiomyopathy: a speckle tracking imaging analysis

Speaker: Doctor S. Charfeddine (Sfax, TN)

Access the full session

Clinical Forum - Mon. 23 May 08:30 - Tues. 24 May 12:30

Speakers: Professor C. Angermann, Doctor J. Baranowski, Doctor D. Fitchett, Professor S. Anker, Doctor S. Charfeddine

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources